MedTrace Logo

Efficacy of an Oral Rehydration Solution Containing the Probiotic Lactobacillus Reuteri Protectis and Zinc in Infants With Acute Gastroenteritis

NCT01886755 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2016-02-23

No results posted yet for this study

Summary

An ORS with L. reuteri DSM 17938 and zinc is expected to reduce duration and severity of symptoms in infants and young children with acute gastroenteritis.

Conditions

  • Acute Gastroenteritis

Interventions

DIETARY_SUPPLEMENT

ORS rehydration solution

DIETARY_SUPPLEMENT

placebo

Sponsors & Collaborators

  • BioGaia AB

    collaborator INDUSTRY

  • Alexandra Papadopoulou

    lead OTHER

Principal Investigators

  • Alexandra Papadopoulou, Dr · Athens Children's Hospital "AGIA SOPHIA"

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
36 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01886755 on ClinicalTrials.gov